Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THR
3376
DELISTED
Thermon Group Holdings
THR
| $452K | ﹤0.01% |
31,031
+7,409
| +31% | +$110K |
|
3377
Domo
DOMO
$184M
| $451K | ﹤0.01% |
14,035
+8,095
| +136% | +$180K |
|
|
CEO
3378
CALL
DELISTED
CNOOC Limited
CEO
| $451K | ﹤0.01% |
4,000
-5,800
| -59% | -$655K |
|
|
NGM
3379
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $450K | ﹤0.01% |
22,830
+449
| +2% | +$8.58K |
|
|
HZNP
3380
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $449K | ﹤0.01% |
8,077
-1,463
| -15% | -$62.6K |
|
3381
Andersons Inc
ANDE
$2.22B
| $447K | ﹤0.01% |
32,498
+3,557
| +12% | +$51.7K |
|
3382
Red Robin
RRGB
$152M
| $447K | ﹤0.01% |
43,782
-30,465
| -41% | -$384K |
|
|
WBT
3383
DELISTED
Welbilt, Inc.
WBT
| $447K | ﹤0.01% |
73,553
+30,361
| +70% | +$164K |
|
3384
Liberty Energy
LBRT
$3.25B
| $445K | ﹤0.01% |
81,387
+53,757
| +195% | +$252K |
|
|
AT
3385
DELISTED
Atlantic Power Corporation
AT
| $445K | ﹤0.01% |
222,802
-83,972
| -27% | -$167K |
|
3386
PUT
Infosys
INFY
$50.7B
| $443K | ﹤0.01% |
45,900
-1,200
| -3% | -$10.7K |
|
3387
Travel + Leisure Co
TNL
$4.7B
| $443K | ﹤0.01% |
15,767
-109,723
| -87% | -$2.97M |
|
|
CNP.PRB
3388
DELISTED
CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S
CNP.PRB
| $443K | ﹤0.01% |
12,444
+5,694
| +84% | +$190K |
|
|
AEGN
3389
DELISTED
Aegion Corp
AEGN
| $443K | ﹤0.01% |
27,919
+2,502
| +10% | +$37.2K |
|
|
PLYM
3390
DELISTED
Plymouth Industrial REIT
PLYM
| $442K | ﹤0.01% |
+34,558
| New | +$459K |
|
|
FRTA
3391
DELISTED
Forterra, Inc
FRTA
| $442K | ﹤0.01% |
39,551
+22,184
| +128% | +$183K |
|
3392
PUT
BorgWarner
BWA
$13.9B
| $441K | ﹤0.01% |
14,200
-41,010
| -74% | -$1.08M |
|
|
SPWR
3393
DELISTED
SunPower Corporation Common Stock
SPWR
| $441K | ﹤0.01% |
88,103
+195
| +0.2% | +$890 |
|
|
FLXN
3394
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $441K | ﹤0.01% |
33,548
+7,332
| +28% | +$76K |
|
3395
PagerDuty
PD
$902M
| $439K | ﹤0.01% |
15,355
-44,075
| -74% | -$1.06M |
|
3396
PUT
Wabtec
WAB
$49.3B
| $438K | ﹤0.01% |
7,600
-27,400
| -78% | -$1.55M |
|
3397
Axogen
AXGN
$2.5B
| $437K | ﹤0.01% |
47,263
+25,075
| +113% | +$225K |
|
3398
PUT
Eaton
ETN
$174B
| $437K | ﹤0.01% |
5,000
-3,700
| -43% | -$305K |
|
3399
Matrix Service
MTRX
$335M
| $437K | ﹤0.01% |
45,206
+4,692
| +12% | +$45.6K |
|
3400
Ameresco
AMRC
$1.36B
| $436K | ﹤0.01% |
15,655
+2,164
| +16% | +$43.6K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.